XERS

Xeris Pharmaceuticals Inc (XERS)

US
$ 4.30990.7%

Price Chart

Key Statistics

Market Cap
$ 784.76M
P/E Ratio
0.00
Revenue (TTM)
$ 222.55M
Volume
1.61M
52W High
$ 6.07
52W Low
$ 1.86
Dividend Yield
0.00%
Beta
0.91

Technicals

50-Day MA
4.6812
200-Day MA
3.5237
52 Week High
6.07
52 Week Low
1.86

About XERS

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Employees
394
Headquarters
Chicago, IL
CEO
Mr. John P. Shannon

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg